Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Müller, Timo D ^a,b   Brönner, Günter ^a,c   Wandolski, Melanie ^a   Carrie, Jophia ^a   Nguyen, Trang T ^d   Greene, Brandon H ^d   Scherag, André ^a   Grallert, Harald ^e   Vogel, Carla I G ^a   Scherag, Susann ^a   Rief, Winfried ^d   Wichmann, Hans Erich ^e   Illig, Thomas ^e   Schäfer, Helmut ^d   Hebebrand, Johannes ^a   Hinney, Anke ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID AMIDASE; AMIDASE; FATTY-ACID AMIDE HYDROLASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GERMANY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OBESITY; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; ALLELE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION;

ADOLESCENT; ADULT; ALLELES; AMIDOHYDROLASES; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77649098597     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-2     Document Type: Article

References (34)

1. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004, 3:771-784. 10.1038/nrd1495, 15340387.
2. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949. 10.1126/science.1470919, 1470919.
3. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995, 215:89-97. 10.1006/bbrc.1995.2437, 7575630.
4. Williams CM, Kirkham TC. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1999, 143:315-317. 10.1007/s002130050953, 10353436.
5. Williams CM, Kirkham TC. Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 2002, 76:241-250. 10.1016/S0031-9384(02)00725-4, 12044596.
6. Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002, 136:550-557. 10.1038/sj.bjp.0704767, 1573386, 12055133.
7. Di Marzo V, Goparaju SK, Wang L, Liu J, Bátkai S, Járai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825. 10.1038/35071088, 11298451.
8. Di Marzo V, De Petrocellis L, Bisogno T, Melck D. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Lipids 1999, 34(Suppl):S319-325. 10.1007/BF02562332, 10419192.
9. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002, 99:10819-10824. 10.1073/pnas.152334899, 125056, 12136125.
10. Puffenbarger RA. Molecular biology of the enzymes that degrade endocannabinoids. Curr Drug Targets CNS Neurol Disord 2005, 4:625-631. 10.2174/156800705774933050, 16375680.
11. Hillard CJ, Wilkison DM, Edgemond WS, Campbell WB. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1995, 257:249-256.
12. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, Jordan J. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005, 54:2838-2843. 10.2337/diabetes.54.10.2838, 2228268, 16186383.
13. Maccarrone M, Di Rienzo M, Finazzi-Agrò A, Rossi A. Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J Biol Chem 2003, 278:13318-13324. 10.1074/jbc.M211248200, 12556536.
14. Lambert DM, Muccioli GG. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. Curr Opin Clin Nutr Metab Care 2007, 10:735-744. 10.1097/MCO.0b013e3282f00061, 18089956.
15. Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) 2005, 29:755-759. 10.1038/sj.ijo.0802954, 15809662.
16. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004, 13:2113-2119. 10.1093/hmg/ddh216, 15254019.
17. Jensen DP, Andreasen CH, Andersen MK, Hansen L, Eiberg H, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O. The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites. J Mol Med 2007, 85:445-449. 10.1007/s00109-006-0139-0, 17216208.
18. Papazoglou D, Panagopoulos I, Papanas N, Gioka T, Papadopoulos T, Papathanasiou P, Kaitozis O, Papatheodorou K, Maltezos E. The Fatty Acid Amide Hydrolase (FAAH) Pro129Thr Polymorphism is not Associated with Severe Obesity in Greek Subjects. Horm Metab Res 2008, 40:907-910. 10.1055/s-0028-1087169, 18819056.
19. Lieb W, Manning AK, Florez JC, Dupuis J, Cupples LA, McAteer JB, Vasan RS, Hoffmann U, O'Donnell CJ, Meigs JB, Fox CS. Variants in the CNR1 and the FAAH Genes and Adiposity Traits in the Community. Obesity (Silver Spring) 2009, 17:755-760. 10.1038/oby.2008.608, 19165169.
20. Hinney A, Hinney A, Bettecken T, Tarnow P, Brumm H, Reichwald K, Lichtner P, Scherag A, Nguyen TT, Schlumberger P, Rief W, Vollmert C, Illig T, Wichmann HE, Schäfer H, Platzer M, Biebermann H, Meitinger T, Hebebrand J. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. Clin Endocrinol Metab 2006, 91:1761-1769.
21. Holle R, Happich M, Lowel H, Wichmann HE, . MONICA/KORA Study Group KORA: a research platform for population based health research. Gesundheitswesen 2005, 67(Suppl 1):S19-S25. 10.1055/s-2005-858235, 16032513, MONICA/KORA Study Group.
22. Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann HE, Rief W, Schäfer H, Hebebrand J. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2007, 2:e1361. 10.1371/journal.pone.0001361, 2137937, 18159244.
23. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schäfer H, Gudermann T, Hebebrand J. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003, 88:4258-4267. 10.1210/jc.2003-030233, 12970296.
24. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 52:506-516. 1682161, 8447318.
25. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893. 10.1086/429864, 1199378, 15789306.
26. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000, 67:146-154. 10.1086/302957, 1287073, 10825280.
27. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002, 70:124-141. 10.1086/338007, 384883, 11719900.
28. Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA 2002, 99:8394-8399. 10.1073/pnas.082235799, 123078, 12060782.
29. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, Lazarus R, Klanderman B, Soto-Quiros ME, Avila L, Silverman EK, Thorleifsson G, Thorsteinsdottir U, Kronenberg F, Vollmert C, Illig T, Fox CS, Levy D, Laird N, Ding X, McQueen MB, Butler J, Ardlie K, Papoutsakis C, Dedoussis G, O'Donnell CJ, Wichmann HE, Celedón JC, Schadt E, Hirschhorn J, Weiss ST, Stefansson K, Lange C. On the replication of genetic associations: timing can be everything!. Am J Hum Genet 2008, 82:849-858. 10.1016/j.ajhg.2008.01.018, 2427263, 18387595.
30. Heid IM, Huth C, Loos RJ, Kronenberg F, Adamkova V, Anand SS, Ardlie K, Biebermann H, Bjerregaard P, Boeing H, Bouchard C, Ciullo M, Cooper JA, Corella D, Dina C, Engert JC, Fisher E, Francès F, Froguel P, Hebebrand J, Hegele RA, Hinney A, Hoehe MR, Hu FB, Hubacek JA, Humphries SE, Hunt SC, Illig T, Järvelin MR, Kaakinen M, Kollerits B, Krude H, Kumar J, Lange LA, Langer B, Li S, Luchner A, Lyon HN, Meyre D, Mohlke KL, Mooser V, Nebel A, Nguyen TT, Paulweber B, Perusse L, Qi L, Rankinen T, Rosskopf D, Schreiber S, Sengupta S, Sorice R, Suk A, Thorleifsson G, Thorsteinsdottir U, Völzke H, Vimaleswaran KS, Wareham NJ, Waterworth D, Yusuf S, Lindgren C, McCarthy MI, Lange C, Hirschhorn JN, Laird N, Wichmann HE. Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design?. PLoS Genet 2009, 5:e1000694. 10.1371/journal.pgen.1000694, 2757909, 19851442.
31. Walley AJ, Asher JE, Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet 2009, 10:431-442. 10.1038/nrg2594, 19506576.
32. Hinney A, Hebebrand J. Three at One Swoop!. Obes Facts 2009, 2:3-8. 10.1159/000200020, 20054198.
33. Den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001, 109:121-124. 10.1007/s004390100505, 11479744.
34. Knapp M, Becker T. Family-based association analysis with tightly linked markers. Hum Hered 2003, 56:2-9. 10.1159/000073727, 14614233.